Training

Whether you want to get the basics or fine tune your skills, Thomson Reuters can help with a variety of targeted training opportunities.
  • Attend one of our regularly scheduled webinar training sessions for overviews of features, tools, and content – find the schedule here
  • Contact us to set up tailored, onsite training sessions at your organization
  • Read through our Quick Reference Guides and FAQs for fast answers to common questions

Recorded Training Sessions

Approved compound indication expansion using biological knowledge and pathway analysis

28th October 2014 00:00

Approved compound indication expansion using biological knowledge and pathway analysis

Indication expansion (also known as drug repositioning, drug repurposing) represents an opportunity to leverage compounds that already have a well-studied safety profiles for new patient cohorts. One main strategy for identifying novel indications for a compound is using a target based approach that combines knowledge on a drugs mechanism of action in tandem with biomarker based knowledge of an indication. This session will walk through this approach within MetaCore using Vandetanib, an approved oncology drug as a starting point of the indication expansion workflow. Specific questions to address using MetaCore’s various functionalities will include:

1.) What experimental evidence is there for Vandetanib inhibition activity?
2.) What diseases have biomarkers with increased mRNA levels of the tyrosine-protein kinase Mer?
3.) What pathways could be effected when Vandetanib engages Mer? How do these pathways overlap with COPD biomarkers? How do these biomarkers connect to each other in a network context?